A novel anti-HER2 antibody GB235 reverses Trastuzumab resistance in HER2-expressing tumor cells in vitro and in vivo

HER2 overexpression is frequently associated with tumor metastasis and poor prognosis of breast cancer. More evidence indicates that HER3 is involved in HER2-resistant therapies. Combination treatments with two or more different monoclonal antibodies are a promising strategy to overcome resistance t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shu, Mengjun, Yan, Hongbin, Xu, Chuanying, Wu, Yan, Chi, Zhaohua, Nian, Weihong, He, Zhuzi, Xiao, Jing, Wei, Hongli, Zhou, Qing, Zhou, Joe X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031383/
https://www.ncbi.nlm.nih.gov/pubmed/32076029
http://dx.doi.org/10.1038/s41598-020-59818-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031383/
https://www.ncbi.nlm.nih.gov/pubmed/32076029
http://dx.doi.org/10.1038/s41598-020-59818-2

Ejemplares similares